Abstract | OBJECTIVE: MATERIALS AND METHODS: Twenty-seven patients met diagnostic criteria confirming the presence of functional PAES and agreed to go ahead with ultrasound-guided BTX-A injection at the level of artery occlusion. Patients were assessed and treated at baseline and given the option for 'top-up' injections at 6 and 12 months. Patients provided subjective symptom reports at 6 and 12 months post intervention. RESULTS: No patients reported being worse off after the intervention; 59% of patients were categorized as having a good response (i.e., initial improvement that was maintained at 12 months), 22% a mixed response (i.e., an initial improvement that subsequently reduced over 12 months) and 19% a poor response (i.e., no difference) to treatment. CONCLUSIONS: Ultrasound-guided BTX-A injection represents a viable alternative to surgery in the treatment of functional PAES. Further study will help determine the optimum dose and frequency of injection to prevent recurrence of symptoms.
|
Authors | Matthew Hislop, Adam Brideaux, Sanjay Dhupelia |
Journal | Skeletal radiology
(Skeletal Radiol)
Vol. 46
Issue 9
Pg. 1241-1248
(Sep 2017)
ISSN: 1432-2161 [Electronic] Germany |
PMID | 28600622
(Publication Type: Journal Article)
|
Chemical References |
- Neuromuscular Agents
- Botulinum Toxins, Type A
|
Topics |
- Adolescent
- Adult
- Aged
- Arterial Occlusive Diseases
(drug therapy)
- Botulinum Toxins, Type A
(therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Neuromuscular Agents
(therapeutic use)
- Popliteal Artery
- Treatment Outcome
- Ultrasonography, Interventional
|